FDA Clearance Tracker · P040050-S013
Macroplastique Implants
Last checked: Nov 20, 2026Latest source record: May 9, 2023 (this decision)Source: openFDAMethods & limitations
Decided
May 9, 2023
Approved
Time to decision
361 days
Received May 13, 2022. Calendar days, including time FDA spent waiting on the applicant.
Pathway
PMA supplement
Normal 180 Day Track No User Fee
Device class
Class III
The decision
- FDA number
- P040050-S013
- Device name
- Macroplastique Implants
- Applicant
- Uroplasty, LLC
- Applicant location
- Minnetonka, MN
- Received
- May 13, 2022
- Decided
- May 9, 2023
- Decision
- Approved
- Supplement type
- Normal 180 Day Track No User Fee
- Reason for supplement
- Labeling Change - PAS
- Original approval
- P040050
Device type
- Device class
- Class III
- Specialty
- GI, Urology & NephrologyUrology
FDA's approval statement
As written in FDA's record.
Approval for modifying the labeling to reflect the findings of the Macroplastique Real-Time Observation of Safety and Effectiveness (ROSE) Registry.
Source documents
Other decisions for Uroplasty, LLC
Matched on the applicant name as FDA recorded it. A company that files under several names will have more.
No other decisions since 2015 under this exact applicant name.
For information only. Nothing on this page is investment, legal, tax or medical advice, and nothing here is an offer to sell or a solicitation of an offer to buy any security. The data comes from public government sources, which can be incomplete, delayed or wrong. Check the original record before relying on it.